期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

前列腺癌的骨转移机制 被引量：1

Mechanisms of bone metastasis in prostate cancer
原文传递
导出
摘要 前列腺癌骨转移的分子与细胞机制仍不清楚。前列腺癌骨转移过程中肿瘤细胞的趋化性，肿瘤细胞与骨骼微环境之间各种分子的相互作用以及肿瘤细胞、破骨细胞、成骨细胞和骨基质之间的恶性循环是近年来前列腺癌骨转移研究的热点。 The molecular and cellular mechanisms of bone metastasis in prostate cancer remain unclear. Current researches focus on chemotaxis of tumor cells in bone metastasis, interactions between tumor cells and bone micro-environment as well as the vicious circle among tumor cells, osteoclasts, osteoblasts and bone matrix .
作者 郦俊(综述) 邹志鹏(综述) 刘思旸(综述) 邓凡(审校)
机构地区 南方医科大学细胞生物学教研室
出处 《国际肿瘤学杂志》 CAS 2010年第8期621-623,共3页 Journal of International Oncology
基金 国家自然科学基金资助项目（30973014）
关键词 前列腺肿瘤 肿瘤转移 成骨细胞 破骨细胞 Prostate neoplasms Neoplasm metastasis Osteoblasts Osteoclasts
分类号 R737.11 [医药卫生—肿瘤]
  • 相关文献

参考文献12

  • 1Porvasnik S,Sakamoto N,Kusmartsev S,et al.Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth.Prostate,2009,69(13):1460-1469. 被引量：1
  • 2van Golen KL,Ying C,Sequeira L,et al.CCL2 induces prostate cancer transendothelial cell migration via activation of the small GTPase Rac.J Cell Biochem,2008,104 (5):1587-1597. 被引量：1
  • 3Li X,Loberg R,Liao J,et al.A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone.Cancer Res,2009,69(4):1685-1692. 被引量：1
  • 4Loberg RD,Ying C,Craig M,et al.CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophnge infiltration.Neop1asia,2007,9(7):556-562. 被引量：1
  • 5Bonfil RD,Dong Z,Trindade Filbo JC,et al.Prostate cancer-associated membrane type l-matrix metalloproteinase:a pivotal role in bone response and intraosseous tumor growth.Am J Pathol,2007,170(6):2100-2111. 被引量：1
  • 6辛华,马雷,连庆文,杨秀娟,罗振国,张鹏霞,李晶,杨波,张菊影.RT-PCR检测前列腺癌患者PSMA mRNA表达的临床意义[J].国际检验医学杂志,2008,29(3):203-205. 被引量：1
  • 7Hankenson KD,James IE,Apone S,et al.Increased osteoblastogenesis and decreased bone resorption protect against ovariectomy-induced bone loss in thrombospondin-2-null mice Matrix Biol,2005,24(5):362-370. 被引量：1
  • 8Mochida Y,Parisuthiman D,Yamauchi M,et al.Biglycan is a positive modulator of BMP-2 induced osteoblast differentiation.Adv Fxp Med Biol,2006,585:101-113. 被引量：1
  • 9Nordstrand A,Nilsson J,Tieva A,et al.Establishment and validation of an in vitro co-culture model to study the interactions between bone and prostate cancer cells.Clin Exp Metastasis,2009,26 (8):945-953. 被引量：1
  • 10Armstrong AP,Miller RE,Jones JC,et al.RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.Prostate,2008,68 (1):92-104. 被引量：1

二级参考文献10

  • 1Umekita Y, Hiipakka RA, Kokontis JM, et al. Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride [J]. Proc Natl Acad Sci USA, 1996, 93 (21): 11802-11807. 被引量：1
  • 2Corey E, Arfman EW, Oswin MM, et al. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages [J]. Urology, 1997, 50(2): 184-188. 被引量：1
  • 3Grasso YZ, Gupta MK, Levin HS, et al. Combined nested RT PCR assay for prostate-specific antigen and prostate-specific membrahe antigen in prostate cancer patients: correlation with patbo logical stage[J]. Cancer Res, 1998, 58(7): 1456-1459. 被引量：1
  • 4Su SL, Huang IP, Fair WR, et al. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression [J]. Cancer Res, 1995, 55(7): 1441-1443. 被引量：1
  • 5Israeli RS, Powell CT, Fair WR,et al. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen [J]. Cancer Res, 1993, 53(2): 227-230. 被引量：1
  • 6Wright GL Jr, Grob BM, Haley C, et al. Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy [J]. Urology, 1996, 48(2): 326-334. 被引量：1
  • 7Murphy GP, Su S, Jarisch J, et al. Serum levels of PSMA [J]. Prostate, 2000, 42(4): 318-319. 被引量：1
  • 8Biragyn A, Surenhu M, Yang D, et al. Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens [J]. J Immunol, 2001, 167(11): 6644- 6653. 被引量：1
  • 9Yang D, Biragyn A, Kwak LW, et al. Mammalian defensins in immunity: more than just microbicidal [J]. Trends Immunol, 2002, 23(6): 291-296. 被引量：1
  • 10曾浩,李虹,张秀辉,林涛,刘卫平,杨宇如.前列腺特异性膜抗原表达的临床意义[J].中华泌尿外科杂志,2003,24(6):391-393. 被引量：8

同被引文献18

  • 1甘洁民,朱汉民.抗酒石酸酸性磷酸酶的测定及临床应用[J].上海医学检验杂志,1997,12(1):31-32. 被引量：13
  • 2郭应禄.前列腺增生和前列腺癌[M].北京:人民卫生出版社,1998:175-242. 被引量：2
  • 3Jemal A, Siegel R, XuJ, et al. Cancer statistics, 2010 I-J-]. Cancer J Clin, 2010, 60(5): 277-300. 被引量：1
  • 4Bubendorf L, Sch6pfer A, Wagner U, et al. Metastat- ic patterns of prostate cancer: an autopsy study of 1, 589 patients[J]. Hum Pathol, 2000, 31(5): 578- 583. 被引量：1
  • 5Coleman R E. Clinical features of metastatic bone dis- ease and risk of skeletal morbidity [J]. Clin Cancer Res, 2006, 12((20 Pt 2): 6243-6249. 被引量：1
  • 6Bokhorst L P, Zhu X, Bul M, et al. Positive predictive value of prostate biopsy indicated by prostate-specific- antigen-based prostate cancer screening: trends over time in a European randomized trial [J]. BJU Int, 2012, 110(10): 1654-1660. 被引量：1
  • 7Naya Y, Okihara K, Evans R B, et al. Efficacy of prostatic fossa biopsy in detecting local recurrence after radical prostatectomy[J]. Urology, 2005, 66(2): 350 -355. 被引量：1
  • 8Roodman G D. Mechanisms of bone metastasis[J]. N Engl J Med, 2004, 350(16): 1655-1664. 被引量：1
  • 9Sapi E. The role of CSF-1 in normal physiology of mammary gland and breast cancer: an update[J]. Exp Bjol Med(Maywood), 2004, 229(1) ; 1-11. 被引量：1
  • 10Brubaker K D, Corey E, Brown L G, et al. Bone mor- phogenetic protein signaling in prostate cancer cell lines [J]. JCellBioehem, 2004, 91(1): 151-160. 被引量：1

引证文献1

国际肿瘤学杂志
2010年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部